Circulating levels of triacylglycerol (TG) is a recognized risk factor for developing
cardiovascular disease, a leading cause of death worldwide. The Institute of Medicine and …

Clinical and epidemiological studies provide support that the polyunsaturated omega-3 fatty
acids eicosapentaenoic acid and docosahexaenoic acid from fish and fish oils are …

For at least 50 yr, polyunsaturated fatty acids (PUFAs) have been studied intensively as
nutrients that protect against cardiovascular disease (CVD). As new mechanisms have been …

Coronary heart disease, stroke, diabetes mellitus, hypertension, cancer, depression
schizophrenia, Alzheimer's disease, and collagen vascular diseases are low-grade systemic …

Considerable research supports cardiovascular benefits of consuming omega-3 PUFA, also
known as (n-3) PUFA, from fish or fish oil. Whether individual long-chain (n-3) PUFA have …

Aims We hypothesised that omega‐3 fatty acids would be an appropriate adjunct therapy for
alleviating the inflammatory response and clinical manifestation in hospitalised patients with …

Numerous clinical trials examining the use of omega-3 long chain polyunsaturated fatty
acids (n-3 LCPUFAs) on various health outcomes have been conducted, and fish oil …

Cardiovascular diseases remain a global challenge, and lipid-associated biomarkers can
predict cardiovascular events. Extensive research on cardiovascular benefits of omega-3 …

Background People with type 2 diabetes mellitus are at increased risk from cardiovascular
disease. Dietary omega‐3 polyunsaturated fatty acids (PUFAs) are known to reduce …

Typical omega 3 polyunsaturated fatty acids (n-3 PUFAs) are docosahexaenoic acid and
eicosapentaenoic acid in the form of fish oils and α linolenic acid from flaxseed oil …